language
    News Information

    News Information

    Focusing on cutting-edge technology and conveying industry voices

    Free opportunity to “break the membrane”! Custom membrane protein expression services—available for a limited time; don’t miss out!

    In the height of summer, when scientific research is at its peak, are you held back by the challenges of membrane protein expression and the high costs of trial-and-error experimentation? Suzhou Perotin Bio’s Summer Research Support Program is now officially launched! Leveraging our proprietary cell-free expression technology, we’ll help you assess the feasibility of expressing your target membrane protein—at zero cost—efficiently addressing the common experimental hurdles of difficult expression and low yields, and accelerating your research progress!

    2026/06/29


    Live Stream Reservation | A Revolution in Protein R&D Efficiency: Cell-Free Protein Expression Meets High-Throughput BLI, Ensuring AI Is No Longer Starved for Data

    The rapid advancement of AI-driven drug discovery is driving an exponential surge in demand for high-quality molecular interaction data. However, traditional protein‑production methods suffer from low throughput and lengthy assay cycles, making them the most significant bottleneck between wet‑lab experiments and AI models. How can we achieve end-to-end automation, spanning rapid protein preparation to high‑throughput affinity screening? And how can we ensure that wet‑lab assays deliver high‑quality inputs that meet the data‑hungry requirements of AI systems?

    2026/06/17


    Cell-free expression opens new avenues for studying membrane protein function.

    Perotin Bio, leveraging its proprietary cell-free protein expression platform, has established a comprehensive product portfolio ranging from assay kits to end-to-end membrane protein expression services. By incorporating folding‑assisting factors such as nanodiscs and detergents into the expression system, the company effectively enhances the solubility and functional activity of challenging membrane proteins, including multi‑transmembrane receptors, transporters, and ion channels. The company has achieved expression levels and activity at structural‑resolution quality for numerous membrane protein targets, significantly shortening the R&D cycle for research clients—from gene to functional protein.

    2026/07/09


    Membrane Protein Expression: Overcoming the Bottlenecks through Cell-Free Systems

    In protein expression research, membrane proteins have long been notorious for their high failure rates. Despite highly mature optimization strategies—such as expression vector engineering, codon optimization, and host system screening—actual R&D pipelines frequently stall at the same frustrating stage: the inability to obtain stable, high-yield expression products.

    2026/07/03


    [Academician-Led, Industry Leaders] 2026 Conference on Cutting-Edge Technologies and Innovative Development in Enzyme Engineering

    July 24–26, 2026 (full-day registration on the 24th) Nanjing City, Jiangsu Province (Guangyuan Holiday Hotel ★★★★★), Intersection of Binhu West Road and Innovation Middle Road, Jiangning District, Nanjing

    2026/06/17


    How can you stand out in synthetic biology competitions? PLD’s cell-free protein expression system boosts your competitive edge!

    Want to stand out in top-tier biology competitions like iGEM (International Genetically Engineered Machine Competition), but feel held back by the tediousness, time‑consuming nature, and high barriers of traditional cell‑based experiments? The PLD Cell‑Free Protein Expression Kit (PLDK003) is designed for biology education and competitions at every stage—from high school through undergraduate and graduate studies. With its ultra‑simple operation, rapid results, and exceptional versatility, it helps your project get ahead and shine!

    2026/06/17


    Highlights | When AI Meets Cell-Free Protein Expression, New Drug Development Ushers in a New Era

    On June 4–5, the 2026 Pharma Future Summit was held as scheduled at the Kempinski Hotel Suzhou Jinji Lake. At the AI session, Gan Mingzhe, Deputy General Manager of Suzhou Perotin Biotechnology Co., Ltd., delivered a keynote presentation, detailing the integration of cell-free protein expression with artificial intelligence and offering fresh insights to address the industry’s key challenges in AI-driven drug development.

    2026/06/10


    Applications and Future Trends of Cell-Free Protein Expression Technology

    Cell-Free Protein Synthesis (CFPS) has grown rapidly in the fields of synthetic and structural biology in recent years. It is steadily evolving from a basic laboratory tool into a vital technology platform for protein engineering and drug discovery. The core of this technology lies in the in vitro reconstitution of transcription and translation systems, enabling the rapid synthesis of target proteins while completely bypassing the complex regulatory networks found inside living cells.

    2026/06/10


    < 1234...20 >